TY - JOUR T1 - Examining sex differences in neurodevelopmental and psychiatric genetic risk in anxiety and depression JF - medRxiv DO - 10.1101/2021.02.22.21251925 SP - 2021.02.22.21251925 AU - Joanna Martin AU - Kimiya Asjadi AU - Leon Hubbard AU - Kimberley Kendall AU - Antonio F. Pardiñas AU - Bradley Jermy AU - Cathryn M. Lewis AU - Bernhard T. Baune AU - Dorret I. Boomsma AU - Steven P. Hamilton AU - Susanne Lucae AU - Patrik K. Magnusson AU - Nicholas G. Martin AU - Andrew M. McIntosh AU - Divya Mehta AU - Ole Mors AU - Niamh Mullins AU - Brenda W. J. H. Penninx AU - Martin Preisig AU - Marcella Rietschel AU - Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium AU - Ian Jones AU - James T. R. Walters AU - Frances Rice AU - Anita Thapar AU - Michael O’Donovan Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/02/23/2021.02.22.21251925.abstract N2 - Anxiety and depression are common mental health disorders and have a higher prevalence in females. They are modestly heritable, share genetic liability with other psychiatric disorders, and are highly heterogeneous. There is evidence that genetic liability to neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD) is associated with anxiety and depression, particularly in females. We investigated sex differences in family history for neurodevelopmental and psychiatric disorders and neurodevelopmental genetic risk burden (indexed by ADHD polygenic risk scores (PRS) and rare copy number variants; CNVs) in individuals with anxiety and depression, also taking into account age at onset.We used two complementary datasets: 1) participants with a self-reported diagnosis of anxiety or depression (N=4,178, 65.5% female; mean age=41.5 years; N=1,315 with genetic data) from the National Centre for Mental Health (NCMH) cohort and 2) a clinical sample of 13,273 (67.6% female; mean age=45.2 years) patients with major depressive disorder (MDD) from the Psychiatric Genomics Consortium (PGC). We tested for sex differences in family history of psychiatric problems and presence of rare CNVs (neurodevelopmental and >500kb loci) in NCMH only and for sex differences in ADHD PRS in both datasets.In the NCMH cohort, females were more likely to report family history of neurodevelopmental and psychiatric disorders, but there were no robust sex differences in ADHD PRS or presence of rare CNVs. There was weak evidence of higher ADHD PRS in females compared to males in the PGC MDD sample, particularly in those with an early onset of MDD.These results do not provide strong evidence of sex differences in neurodevelopmental genetic risk burden in adults with anxiety and depression. This indicates that sex may not be a major index of neurodevelopmental genetic heterogeneity, that is captured by ADHD PRS and rare CNV burden, in adults with anxiety and depression.Competing Interest StatementMOD, JTRW and IJ have received a collaborative research grant from Takeda Pharmaceuticals. Takeda played no part in the conception, design, implementation, or interpretation of this study. CML is on the Scientific Advisory Board of Myriad Neuroscience. All other authors report no conflicts of interest.Funding StatementJM was supported by a Ser Cymru II COFUND Fellowship from the Welsh Government (grant no. 663830 - CU189) and a NARSAD Young Investigator Grant from the Brain & Behavior Research Foundation (grant no. 27879). LH, AFP, and JTRW were supported by an MRC Mental Health Data Pathfinder grant (MC-PC-17212). CML and BJ are part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. KK was funded by a Wellcome Trust Research Training Fellowship. The National Centre for Mental Health (NCMH) is funded by Welsh Government through Health and Care Research Wales (grant number: 514032). The PGC has received core funding from the US National Institute of Mental Health (5 U01MH109528-03). MOD, CML and the PGC are supported from the National Institute of Mental Health of the National Institutes of Health under Award Number U01MH109514. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval for the NCMH was obtained from the Wales Research Ethics Committee and this specific study was also approved by the Cardiff University School of Medicine Research Ethics Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNCMH data are available to External Collaborators via collaboration with NCMH Core Team members or Internal Collaborators. Further information can be obtained by contacting the NCMH Team. PGC MDD data for secondary analyses are available via collaboration with PGC researchers, with details available online. https://www.ncmh.info/contact/ https://www.med.unc.edu/pgc/shared-methods/data-access-portal/ ER -